GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Shanghai Gentech Co Ltd (SHSE:688596) » Definitions » EBIT

Shanghai Gentech Co (SHSE:688596) EBIT : ¥526 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shanghai Gentech Co EBIT?

Shanghai Gentech Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥254 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥526 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai Gentech Co's annualized ROC % for the quarter that ended in Sep. 2024 was 18.31%. Shanghai Gentech Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 42.88%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shanghai Gentech Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 4.78%.


Shanghai Gentech Co EBIT Historical Data

The historical data trend for Shanghai Gentech Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Gentech Co EBIT Chart

Shanghai Gentech Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only 106.51 149.30 187.02 286.25 466.46

Shanghai Gentech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.18 140.31 37.31 94.35 254.09

Competitive Comparison of Shanghai Gentech Co's EBIT

For the Specialty Industrial Machinery subindustry, Shanghai Gentech Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Gentech Co's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Shanghai Gentech Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai Gentech Co's EV-to-EBIT falls into.



Shanghai Gentech Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥526 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Gentech Co  (SHSE:688596) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai Gentech Co's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=1135.208 * ( 1 - 1.76% )/( (6169.71 + 6013.335)/ 2 )
=1115.2283392/6091.5225
=18.31 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9153.854 - 2040.507 - ( 943.637 - max(0, 5404.695 - 7190.936+943.637))
=6169.71

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9309.799 - 2194.3 - ( 1102.164 - max(0, 5247.194 - 7167.195+1102.164))
=6013.335

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai Gentech Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1016.34/( ( (1215.809 + max(1036.952, 0)) + (1366.704 + max(1120.754, 0)) )/ 2 )
=1016.34/( ( 2252.761 + 2487.458 )/ 2 )
=1016.34/2370.1095
=42.88 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1557.185 + 3906.484 + 228.503) - (2040.507 + 0 + 2614.713)
=1036.952

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1693.119 + 3624.006 + 237.338) - (2194.3 + 0 + 2239.409)
=1120.754

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shanghai Gentech Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=526.054/10999.433
=4.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Gentech Co EBIT Related Terms

Thank you for viewing the detailed overview of Shanghai Gentech Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Gentech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 55 Chunyong Road, Building 2, Minhang District, Shanghai, CHN, 201108
Shanghai Gentech Co Ltd is engaged in designing, production, installation and supporting services of gas chemical supply system. The company is also engaged in designing and installation of water treatment systems, recycling system, clean fluid system, and other systems.
Executives
Yu Wen Ying senior management
Xie Hai Wen Director
Chen Yue senior management
Ceng Qing Teng Core technical personnel
Shi Ke Cheng senior management
senior management
Zhou Ming Zheng Supervisors, core technical personnel
Li Dong Sheng Core technical personnel

Shanghai Gentech Co Headlines

No Headlines